Predicting Treatment Adherence of Tuberculosis Patients at Scale
Tuberculosis (TB), an infectious bacterial disease, is a significant cause of death, especially in low-income countries, with an estimated ten million new cases reported globally in $2020$. While TB is treatable, non-adherence to the medication regimen is a significant cause of morbidity and mortality. Thus, proactively identifying patients at risk of dropping off their medication regimen enables corrective measures to mitigate adverse outcomes. Using a proxy measure of extreme non-adherence and a dataset of nearly $700,000$ patients from four states in India, we formulate and solve the machine learning (ML) problem of early prediction of non-adherence based on a custom rank-based metric. We train ML models and evaluate against baselines, achieving a $\sim 100\%$ lift over rule-based baselines and $\sim 214\%$ over a random classifier, taking into account country-wide large-scale future deployment. We deal with various issues in the process, including data quality, high-cardinality categorical data, low target prevalence, distribution shift, variation across cohorts, algorithmic fairness, and the need for robustness and explainability. Our findings indicate that risk stratification of non-adherent patients is a viable, deployable-at-scale ML solution. As the official AI partner of India's Central TB Division, we are working on multiple city and state-level pilots with the goal of pan-India deployment.
Code (0)
등록된 구현이 없습니다.
Tasks
FairnessSimilar Papers 제목 키워드 기반
Learning to Prescribe Interventions for Tuberculosis Patients Using Digital Adherence Data
Digital Adherence Technologies (DATs) are an increasingly popular method for verifying patient adherence to many medications. We analyze data from one city served by 99DOTS, a phone-call-based DAT deployed for Tuberculos…
A Machine Learning Approach for Predicting Therapeutic Adherence to Osteoporosis Treatment
Osteoporosis is a great disability burden with an expected cost increase of almost 50% by 2025. Due to its long term treatment, 50–70% of the patients withdraw from their osteoporosis medications within the first year of…
BIG-bench Machine LearningManagementEvaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator
Tuberculosis (TB) is one of the deadliest diseases worldwide, with 1,5 million fatalities every year along with potential devastating effects on society, families and individuals. To address this alarming burden, vaccine…
Transforming Tuberculosis Care: Optimizing Large Language Models For Enhanced Clinician-Patient Communication
Tuberculosis (TB) is the leading cause of death from an infectious disease globally, with the highest burden in low- and middle-income countries. In these regions, limited healthcare access and high patient-to-provider r…
Language ModelingLanguage ModellingLarge Language ModelPredicting Injectable Medication Adherence via a Smart Sharps Bin and Machine Learning
Medication non-adherence is a widespread problem affecting over 50% of people who have chronic illness and need chronic treatment. Non-adherence exacerbates health risks and drives significant increases in treatment cost…
BIG-bench Machine Learning